Oliver Schlüter

Dr. Schlüter is the CFO and a co-founder of Dermaliq. He serves as Dermaliq’s Chairman of the Board of Directors. In parallel, Dr. Schlüter continues serving as Novaliq’s CFO, a position he has held since 2015. Prior to this Dr. Schlüter was CFO of CureVac GmbH from 2010 to 2015 where he was instrumental in the transformation of a 70 employee R&D-driven company to a 170-employee customer-centric and value-focused corporation that entered into several strategic partnerships with in-house cGMP-manufacturing. During his time at CureVac the company’s value increased more than tenfold and reached unicorn status with a value of more than $1bn. During the past 15 years in Biotech/Pharma he secured more than $400m cash for the organizations he served. Dr. Schlüter has 25+ years of professional experience within the fields of Finance and Life Sciences. He holds a PhD in computational finance and also studied business. administration.